Scientists have developed a successful method to make truly personalised predictions of future disease outcomes for patients with certain types of chronic blood cancers. Wellcome Sanger Institute researchers and collaborators combined extensive genetic and clinical information to predict the prognosis for patients with myeloproliferative neoplasms. Published in the New England Journal of Medicine, the research identified eight different genetic subgroups of the disease and could lead to personalised medicine for patients with these blood cancers.

The genomes of 25 UK species have been read for the first time by scientists at the Wellcome Sanger Institute and their collaborators. The 25 completed genome sequences, announced today (4 October) on the Sanger Institute’s 25th anniversary, will lead to future studies to understand the biodiversity of the UK and aid the conservation and understanding of our species.

Cell Model Passports, a user-friendly website described in Nucleic Acids Research will enable cancer researchers in both academia and industry not only to access high-quality raw and processed genomic and functional datasets, but also to select the best model(s) for their research. Before now, finding the most relevant cancer model(s) has often been difficult and time consuming – the Passports will streamline this process.

16 newly sequenced mouse genomes have revealed new gene structures and coding loci absent from the current reference strain. This discovery could impact future research in genetics, drug development and beyond.

Normal skin contains a patchwork of mutated cells, yet very few go on to eventually form cancer and scientists have now uncovered the reason why. Researchers at the Wellcome Sanger Institute and MRC Cancer Unit, University of Cambridge genetically engineered mice to show that mutant cells in skin tissue compete with each other, with only the fittest surviving.

The study published today (26 September) in Nature will help researchers understand how an individual’s whole genetic make-up can modify the effect of rare damaging variants typically thought to cause these developmental disorders. They also revealed that common genetic variants known to increase the risk of conditions such as schizophrenia also increased the risk of rare developmental disorders.

This October, the Wellcome Sanger Institute, one of the world’s leading centres of genomic research, celebrates 25 years of research and discovery through genome sequencing. In the same week, the NHS will become the first health service in the world to routinely offer genomic medicine as part of patient care.

LifeLab has launched an exciting programme of events for Friday 28th and Saturday 29th September, to transform parts of Cambridge and Peterborough into centres of discovery and opportunity for the weekend. Most of the events in shopping centres , cafes and public spaces are free, with a range of activities to inspire all ages and interests.

Adult humans have many more blood-creating stem cells in their bone marrow than previously thought, ranging between 50,000 and 200,000 stem cells. Researchers from the Wellcome Sanger Institute and Wellcome – MRC Cambridge Stem Cell Institute developed a new approach for studying stem cells, based on methods used in ecology.

New experimental research by the University of Glasgow and the Wellcome Sanger Institute published in Nature Microbiology, demonstrates that a regulator protein, AP2-G, may hold the key to finding new approaches to prevent malaria.